GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS)

CUSIP: G3855L106

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 6 signals
Share change
-696,521
SEC-reported price per share
$9.72
Number of holders
32
Value change
-$7,759,406
Number of buys
12
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
61,857,977

Security key

G3855L106

Report period

Q4 2022

Institutions

32

Top holders

10

Ownership snapshot

Top reported holders of GHRS - GH Research PLC - Ordinary Shares, nominal value $0.025 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Comparable ownership Top 5
BVF INC/IL 15%
FMR LLC 8.1%
RA CAPITAL MANAGEMENT, L.P. 7.9%
Venrock Adviser, LLC 5.4%
RTW INVESTMENTS, LP 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
15%
$107,777,000
9,275,158 shares
30 Sep 2022
FMR LLC
13F
Company
13F
8.1%
$58,247,000
5,012,664 shares
30 Sep 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
7.9%
$56,919,000
4,898,373 shares
30 Sep 2022
Venrock Adviser, LLC
13F
Company
13F
5.4%
$38,731,000
3,333,154 shares
30 Sep 2022
RTW INVESTMENTS, LP
13F
Company
13F
3.5%
$25,203,000
2,168,957 shares
30 Sep 2022
ORBIMED ADVISORS LLC
13F
Company
13F
2.6%
$18,848,000
1,622,060 shares
30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
32
Shares
30,892,511
Rows available
32
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
33
Q4 2022 holders
32
Holder diff
-1
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .